• Duramorph (preservative-free) injection, West-Ward
  0.5 mg/mL, 10 mL ampule, 10 count (NDC 00641-6020-10)

• • Astramorph injection has been unavailable since 2012. Fresenius Kabi changed manufacturing sites and cannot estimate if Astramorph will return.
  • Pfizer states the shortage is due to manufacturing delays. Pfizer discontinued morphine ADD-Vantage vials in January 2017.
  • Pfizer anticipates a shortage of several prefilled syringe products, including morphine, starting in late-July 2017 due to issues at a manufacturing facility. To minimize the impact of the shortage, Pfizer is prioritizing production of certain morphine Carpuject syringes. Pfizer expects the shortage of prefilled syringe products to recover by late-first quarter 2018.
  • West-Ward launched several new morphine sulfate products in late-September 2015. They are not actively marketing the 15 mg/mL 1 mL vials or the 8 mg/mL 1 mL vials (NDC 00641-6075-25). They are still marketing the 8 mg/mL 1 mL vials with NDC 00641-6126-25.

• Duramorph (preservative-free) injection, West-Ward

Estimated Resupply Dates

• • Pfizer has morphine 0.5 mg/mL 10 mL preservative-free vials and 1 mg/mL 10 mL preservative-free vials on back order and the company estimates a release date of early-August 2017. The 2 mg/mL 1 mL Carpuject syringes are on back order and the company estimates a release date of mid-July 2017. The 50 mg/mL 50 mL vials are on back order and the company estimates a release date of late-July 2017.
  • West-Ward has Infumorph 10 mg/mL 20 mL and 25 mg/mL 20 mL preservative-free ampules on back order and the company estimates a release date of July or August 2017. Duramorph 0.5 mg/mL 10 mL ampules are on back order and the company estimates a release date of mid-July 2017. Morphine 4 mg/mL 1 mL vials and 8 mg/mL 1 mL vials are on a weekly allocation.